UT DSAEK

Article

We are pleased to notify you of a groundbreaking event : the very first live DSAEK surgery transmitted on the web.

We are pleased to notify you of a groundbreaking event : the very first live DSAEK surgery transmitted on the web.

On Friday June 25th, at 3pm (GMT +2) Pr. Massimo Busin (from Forli, Italy) will perform three live surgical procedures with the latest, very promising technique in Endothelial Keratoplasty, Ultra-Thin DSAEK.

This live surgery event will be streamed in real time over the internet in a high definition quality. Questions may be sent during the event by the web attendance to Pr. M. Busin and Dr. A.K. Patel.

Click here to register

To connect, please follow the instructions below:

- On or before June 25th:

Go to www.morialivesurgery.com

Complete the registration form. You will receive your login and password by email.

- On June 25th:

Go to www.morialivesurgery.com

Enter your login and password to access to the live page

Please mark the date on your calendar and plan your moderator questions

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.